Please login to the form below

Not currently logged in
Email:
Password:

IDF appoints new CEO

Petra Wilson to head global diabetes organisation

IDF CEOThe International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its new CEO.

Dr Wilson joins the global organisation, which represents more than 200 diabetes associations, from network and IT firm Cisco where she was senior director of the European health and care business.

She gained experience in this role working with the World Heath Organization, the European Commission and governments on the use of communications technologies in healthcare systems.

Her other healthcare roles include serving as director of the European Health Management Association and as scientific officer for the European Commission.

This career follows a background in law, with Dr Wilson a former lecturer in law at the University of Nottingham having completed a doctorate at Oxford University in public health law.

She said: “Diabetes is one of the most pressing health challenges globally, which demands that people, organisations, communities and nations work together to create a better future for those affected by the disease. IDF has a deservedly high reputation as a forthright advocate for people with diabetes, and I look forward to being part of such a dynamic global movement.”

8th November 2013

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Star’s a full service resourcing house and for almost 12 years we’ve recruited the best people for pharma, medical devices...

Latest intelligence

A new reality for healthcare
When mobile phones came onto the mass market it would have been difficult to see how they were to develop into the ubiquitous multimedia devices they are now. Their power,...
Digital-green-grey.jpg
Are you getting these benefits from your digital technology?
Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?...
Alzheimer's: the numbers we cannot forget
In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...

Infographics